Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
Rheumatology Advances in Practice|November 25, 2022
Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilarsAlannah Quinlivan, Susan Lester, Claire Barrett, et al.Contemporary Clinical Trials|November 18, 2005
A pragmatic 2 x 2 x 2 factorial cluster randomized controlled trial of educational outreach visiting and case conferencing in palliative care-methodology of the Palliative Care Trial [ISRCTN 81117481]Amy P Abernethy, David C Currow, Roger Hunt, et al.Journal of Pain and Symptom Management|October 30, 2012
Delivery strategies to optimize resource utilization and performance status for patients with advanced life-limiting illness: results from the "palliative care trial" [ISRCTN 81117481]Amy P Abernethy, David C Currow, Tania Shelby-James, et al.Palliative Medicine|April 11, 2022
Pharmacovigilance in hospice/palliative care: Net effect of amitriptyline or nortriptyline on neuropathic pain: UTS/IMPACCT Rapid programme international consecutive cohortAkram Hussein, Madeline Digges, Sungwon Chang, et al.BMJ Supportive & Palliative Care|October 18, 2014
Pharmacovigilance in hospice/palliative care: net effect of gabapentin for neuropathic painChristine Sanderson, Stephen J Quinn, Meera Agar, et al.BMJ Supportive & Palliative Care|February 25, 2016
Pharmacovigilance in hospice/palliative care: net effect of pregabalin for neuropathic painChristine Sanderson, Stephen J Quinn, Meera Agar, et al.Chronic Respiratory Disease|January 7, 2020
Pragmatic randomised controlled trial of a personalised intervention for carers of people requiring home oxygen therapyPeter Frith, Ruth Sladek, Richard Woodman, et al.Palliative Medicine|June 7, 2021
Clinicians' delirium treatment practice, practice change, and influences: A national online surveyAnnmarie Hosie, Meera Agar, Gideon A Caplan, et al.BMJ Open|February 20, 2020
Risk of opioid misuse in people with cancer and pain and related clinical considerations: a qualitative study of the perspectives of Australian general practitionersTim Luckett, Toby Newton-John, Jane Phillips, et al.Drugs & Aging|November 24, 2022
Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trialGereltuya Dorj, Nibu Parameswaran Nair, Luke Bereznicki, et al.Pageof 11